Ampio Pharmaceuticals (NYSE:AMPE) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Rating) in a report released on Sunday. The firm set a “sell” rating on the stock. Shares of Ampio Pharmaceuticals stock opened at $0.28 on Friday. The business’s fifty day simple moving average is $0.44. Ampio Pharmaceuticals has a 1 year low of $0.21 […]

Related Keywords

United States ,Thomson Reuter ,Ampio Pharmaceuticals ,Ampio Pharmaceuticals Get Rating ,Ampio Pharmaceuticals Inc ,Get Rating ,Inhaled Ampion ,Respiratory Distress Due ,Nyse Ampe ,Ampe ,Medical ,Initiated Coverage ,Stocknews Com ,